-+ 0.00%
-+ 0.00%
-+ 0.00%

◇The Nikkei Stock Exchange reports that Chugai Pharmaceutical is in a buying mood, as the U.S. FDA has approved Eli Lilly's oral obesity drug.

NIKKEI QUICK·04/02/2026 00:07:04

登录查看新闻详情